Caption Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.72M | Buy |
504,471
+322,571
| +177% | +$3.02M | 0.05% | 49 |
|
|
2025
Q1 | $2.23M | Sell |
181,900
-32,767
| -15% | -$403K | 0.02% | 112 |
|
|
2024
Q4 | $2.84M | Buy |
214,667
+194,341
| +956% | +$2.57M | 0.03% | 88 |
|
|
2024
Q3 | $391K | Buy |
+20,326
| New | +$391K | 0.01% | 255 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 866 |
|
|
2023
Q4 | – | Sell |
-9,302
| Closed | -$135K | – | 832 |
|
|
2023
Q3 | $135K | Sell |
9,302
-2,498
| -21% | -$36.3K | ﹤0.01% | 324 |
|
|
2023
Q2 | $247K | Sell |
11,800
-3,200
| -21% | -$67K | ﹤0.01% | 230 |
|
|
2023
Q1 | $317K | Buy |
+15,000
| New | +$317K | 0.01% | 218 |
|
|
2022
Q1 | – | Sell |
-46,226
| Closed | -$1.01M | – | 936 |
|
|
2021
Q4 | $1.01M | Buy |
+46,226
| New | +$1.01M | 0.01% | 263 |
|
|
2021
Q3 | – | Sell |
-19,629
| Closed | -$337K | – | 885 |
|
|
2021
Q2 | $337K | Sell |
19,629
-33,371
| -63% | -$573K | ﹤0.01% | 299 |
|
|
2021
Q1 | $1.19M | Buy |
53,000
+20,000
| +61% | +$447K | 0.03% | 151 |
|
|
2020
Q4 | $733K | Buy |
33,000
+21,886
| +197% | +$486K | 0.02% | 142 |
|
|
2020
Q3 | $164K | Buy |
+11,114
| New | +$164K | ﹤0.01% | 283 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 587 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 550 |
|
|
2019
Q4 | – | Sell |
-500
| Closed | -$4K | – | 508 |
|
|
2019
Q3 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 253 |
|
|
2019
Q1 | – | Sell |
-84,666
| Closed | -$377K | – | 366 |
|
|
2018
Q4 | $377K | Buy |
84,666
+32,666
| +63% | +$145K | 0.03% | 133 |
|
|
2018
Q3 | $421K | Buy |
+52,000
| New | +$421K | 0.02% | 141 |
|